PHAT - Phathom Pharmaceuticals, Inc.
IEX Last Trade
6.62
0.200 3.021%
Share volume: 1,191,003
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.28%
PREVIOUS CLOSE
CHG
CHG%
$6.42
-0.32
-0.05%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-06-14 | 2023-08-10 | 2023-11-09 | 2024-11-07 | 2024-06-14 | 2024-08-08 | 2024-11-07 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 682.000 K | 1.912 M | 7.324 M | 16.352 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 167.000 K | 426.000 K | 1.376 M | 2.356 M | |
| Gross profit | 0.000 | 0.000 | 0.000 | 515.000 K | 1.486 M | 5.948 M | 13.996 M | |
| nan% | nan% | inf% | 188.54% | 300.27% | 135.31% | |||
| Operating expenses | 30.077 M | 31.701 M | 35.659 M | 70.390 M | 71.440 M | 83.248 M | 84.792 M | |
| Selling general and admin | 18.598 M | 18.937 M | 23.396 M | 56.997 M | 62.010 M | 75.872 M | 76.099 M | |
| Research and development | 11.479 M | 12.764 M | 12.263 M | 13.393 M | 9.430 M | 7.376 M | 8.693 M | |
| Total expenses | 30.077 M | 31.701 M | 35.659 M | 70.390 M | 71.440 M | 83.248 M | 84.792 M | |
| 5.40% | 12.49% | 97.40% | 1.49% | 16.53% | 1.85% | |||
| Operating income | -30.077 M | -31.701 M | -35.659 M | -69.875 M | -69.954 M | -77.300 M | -70.796 M | |
| Ebit | -30.057 M | -31.698 M | -35.856 M | -69.889 M | -69.997 M | -77.306 M | -70.804 M | |
| Pretax income | -37.814 M | -40.965 M | -43.243 M | -79.570 M | -82.852 M | -91.446 M | -85.577 M | |
| 8.33% | 5.56% | 84.01% | 4.12% | 10.37% | -6.42% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -37.814 M | -40.965 M | -43.243 M | -79.570 M | -82.852 M | -91.446 M | -85.577 M | |
| -8.33% | -5.56% | -84.01% | -4.12% | -10.37% | 6.42% |